Antibodies can be used as drugs that experts say could lead to the development of a flu vaccine that would not have to be changed yearly.
Clinical trials could begin within three years.
MORE L.A. BREAKING NEWS, WEATHER, TRAFFIC, SPORTS
SEND TIP || REPORT TYPO || TWEET @abc7 || WIDGET